Recombinant Human Kallikrein 1 Protein, CF

R&D Systems | Catalog # 2337-SE

R&D Systems
Loading...

Key Product Details

  • R&D Systems NS0-derived Recombinant Human Kallikrein 1 Protein (2337-SE)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

NS0

Accession Number

Structure / Form

Pro form

Applications

Enzyme Activity
Loading...

Product Specifications

Source

Mouse myeloma cell line, NS0-derived human Kallikrein 1 protein
Ile25-Ser262, with an N-terminal human KLK-5 propeptide (Val23-Arg66) and a C-terminal 10-His tag

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Val23 (KLK-5 propeptide, Accession # Q9Y337)

Predicted Molecular Mass

32 kDa

SDS-PAGE

41 kDa, 45 kDa, 49 kDa and 56 kDa, reducing conditions

Activity

Measured by its ability to cleave a flourogenic peptide substrate Pro-Phe-Arg-7-amido-4-methylcoumarin (PFR-AMC).
The specific activity is >1,500 pmol/min/µg, as measured under the described conditions.

Formulation, Preparation, and Storage

2337-SE
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl and CaCl2.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: Kallikrein 1

Kallikrein 1 (KLK1), also known as tissue kallikrein, is a member of human tissue kallikrein family (1). The best known physiological function of KLK1 is the cleavage of kininogen to release the vasoactive kinin peptide (bradykinin or lysyl-bradykinin), which regulates vasodilation, blood pressure reduction, smooth muscle relaxation and contraction, pain induction and inflammation (2). In addition, KLK1 may play a role in angiogensis and tumorigenesis (2). Human KLK1 precursor contains a signal peptide (residues1 to 18), a short pro peptide (residues 19 to 24) and a mature chain (residues 25 to 262). The purified rhKLK1 contains the mature chain and the propeptide from human KLK5. After being activated by thermolysin, rhKLK1 is active against a fluorogenic peptide substrate described above.

References

  1. Yousef, G.M. and E.P. Diamandis (2001) Endocrine Rev. 22:184.
  2. Chao, J. (2004) in Handbook of Proteolytic Enzymes, Barrett, A.J. et al. eds. pp. 1577 - 1580.

Alternate Names

KLK1

Entrez Gene IDs

3816 (Human); 16612 (Mouse)

Gene Symbol

KLK1

UniProt

Additional Kallikrein 1 Products

Product Documents for Recombinant Human Kallikrein 1 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Kallikrein 1 Protein, CF

For research use only

Citations for Recombinant Human Kallikrein 1 Protein, CF

Customer Reviews for Recombinant Human Kallikrein 1 Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Kallikrein 1 Protein, CF and earn rewards!

Have you used Recombinant Human Kallikrein 1 Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human Kallikrein 1 Protein, CF (2337-SE):

Materials
  • Activation Buffer: 50 mM Tris, 10 mM CaCl2, 150 mM NaCl, pH 7.5 (TCN)
  • Assay Buffer: 50 mM CHES, 250 mM NaCl, pH 10.0
  • Recombinant Human Kallikrein 1 (rhKLK1) (Catalog # 2337-SE)
  • Bacterial Thermolysin (Thermolysin) (Catalog # 3097-ZN)
  • 1,10 Phenanthroline (Sigma, Catalog # 320056), 0.6 M stock in DMSO
  • Substrate: Pro-Phe-Arg-AMC (Bachem, Catalog # I-1295), 10 mM stock in DMSO
  • F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
  • Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
  1. Dilute rhKLK1 to 200 µg/mL in Activation Buffer.
  2. Dilute Thermolysin to 2 µg/mL in Activation Buffer.
  3. Combine 20 µL of diluted rhKLK1 with 20 µL of diluted Thermolysin for a final concentrations of 100 µg/mL and 1 µg/mL respectively.
  4. Incubate at 37 °C for 1 hour.
  5. Stop the reaction with 40 µL of 20 mM 1,10 Phenanthroline for a final concentration of 10 mM.
  6. Dilute incubated rhKLK1 to 0.4 ng/µL in Assay Buffer.
  7. Dilute Substrate to 200 µM in Assay Buffer.
  8. Load 50 µL of the 0.4 ng/µL rhKLK1 in a plate, and start the reaction by adding 50 µL of 200 µM Substrate. Include a Substrate Blank containing 50 µL assay buffer and 50 µL of 200 µM Substrate.
  9. Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively in kinetic mode for 5 minutes.
  10. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)

     *Adjusted for Substrate Blank

     **Derived using calibration standard 7-Amino, 4-Methyl Coumarin (Sigma, Catalog # A-9891).

Per Well:

  • rhKLK1: 0.02 µg
  • Substrate: 100 µM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes
Loading...